Amar Kishan News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Highlights from CBC News, The Guardian, Reuters and others.

Black men with advanced prostate cancer less likely to receive crucial treatment, study finds. UCLA-led study shows Black men are 24% less likely to be prescribed novel hormone therapy compared to white men.

A new study led by investigators at the UCLA Health Jonsson Comprehensive Cancer Center found Black men diagnosed with more advanced stages of prostate cancer are significantly less likely to be prescribed novel hormone therapy than other racial and ethnic groups – including white or Latino men – despite the therapy being proven to effectively control the growth of prostate tumors and extend the lives of men with the disease.

A recent meta-analysis addresses controversies surrounding the relevance of biochemical recurrence (BCR) as a surrogate endpoint for overall survival in trials of localized disease.

A UCLA-led study found treatments that reduce the risk of being diagnosed with a cancer recurrence based on rising prostate-specific antigen (PSA) levels after radiotherapy, commonly referred to as biochemical recurrence, do not necessarily improve a patient's long-term overall survival.